Monofloxofta (Ofloxacin)

Ofloxacin, the active ingredient in Monofloxofta, is a fluoroquinolone antibiotic presented as an ophthalmic solution for ocular use. It treats bacterial eye infections such as conjunctivitis and keratitis in both adults and children.

GNH USA supplies Monofloxofta as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Monofloxofta is indicated for bacterial eye infections, targeting the ocular surface and corneal tissues.

- Bacterial conjunctivitis: reduces bacterial load and accelerates resolution of redness, discharge, and irritation. - Bacterial keratitis: eradicates causative organisms to promote corneal healing and preserve vision. - Other bacterial eye infections: treats conditions such as blepharitis and corneal ulceration caused by susceptible bacteria.

Ophthalmic administration of Ofloxacin may be associated with local and systemic adverse reactions.

Common Side Effects: - Eye irritation: mild burning or stinging upon instillation. - Redness: transient conjunctival hyperemia. - Tearing: increased lacrimation. - Foreign body sensation: feeling of grit in the eye. - Blurred vision: temporary visual disturbance after dosing. - Photophobia: sensitivity to light.

Serious or Rare Side Effects: - Allergic reaction: swelling, rash, or hives around the eye. - Corneal ulceration: worsening of corneal lesions. - Severe eye pain: intense discomfort indicating possible toxicity. - Vision loss: rare but potentially permanent visual impairment. - Stevens‑Johnson syndrome: extremely rare systemic skin reaction.

Before prescribing Monofloxofta, clinicians should consider the following precautions.

- Assess allergy: confirm no hypersensitivity to fluoroquinolones or other ophthalmic agents. - Avoid use in patients with known hypersensitivity to Ofloxacin or related compounds. - Monitor for signs of corneal toxicity: discontinue if ulceration or worsening occurs. - Use with caution in contact lens wearers: advise removal of lenses during treatment. - Store at room temperature: keep in original container, protect from light and moisture.

Ofloxacin eye drops can interact with other medications; awareness of these interactions helps minimize risk.

Major Interactions (Avoid): - Systemic fluoroquinolones: concurrent use may increase risk of tendon or cartilage toxicity. - Corticosteroid eye drops: may mask infection signs and delay healing. - Non‑steroidal anti‑inflammatory eye drops: potential for delayed corneal epithelial repair.

Moderate Interactions (Monitor Closely): - Anticholinergic ophthalmic agents: may reduce tear production and affect drug distribution. - Herbal supplements containing quinine: possible additive QT‑interval prolongation. - Vitamin A derivatives (retinoids): may influence corneal epithelial turnover.